Sort
40,608 grants matching “prostate cancer”
The aberrant androgen receptor underlies abiraterone/enzalutamide resistance
$370,575Jun Luo · Johns Hopkins University · R01 · FY2017 · CA
Development of small molecules for ERG ablation in prostate cancer
$370,575Ralf Kittler · Ut Southwestern Medical Center · R01 · FY2018 · CA
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer
$370,575Min Sup Song · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Studies of the Antifungal Drug Itraconazole As A Novel Inhibitor of Angiogenesis
$370,575Jun O. Liu · Johns Hopkins University · R01 · FY2015 · CA
Development of small molecules for ERG ablation in prostate cancer
$370,575Ralf Kittler · Ut Southwestern Medical Center · R01 · FY2020 · CA
The aberrant androgen receptor underlies abiraterone/enzalutamide resistance
$370,575Jun Luo · Johns Hopkins University · R01 · FY2016 · CA
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
$370,575Guocan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Role of MED1 in the AR-dependent transcription in advanced prostate cancer
$370,575Irfan Ahmed Asangani · University Of Pennsylvania · R01 · FY2020 · CA
The aberrant androgen receptor underlies abiraterone/enzalutamide resistance
$370,575Jun Luo · Johns Hopkins University · R01 · FY2018 · CA
Managed Care Penetration and Cancer Care
$370,556Harvard University (Medical School) · R01 · FY2002 · CA
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis
$370,552Edward L Schwartz · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Project 2: Targeting DNA replication in BRCA-associated breast cancer
$370,550Bing Xia · Rbhs -Cancer Institute Of New Jersey · P01 · FY2021 · CA
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC
$370,489Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2022 · CA
Interactions and Functions of p14ARF in Cancer
$370,484Ruth A Gjerset · Sidney Kimmel Cancer Center · R01 · FY2008 · CA
Interactions and Functions of p14ARF in Cancer
$370,484Ruth A Gjerset · Sidney Kimmel Cancer Center · R01 · FY2007 · CA
Parp Function in Prostate Cancer
$370,478Bryce M Paschal · University Of Virginia · R01 · FY2017 · CA
Dissecting mechanisms of sensitivity to B7-H3 (CD276)-targeted therapeutics in prostate cancer (PC)
$370,476Justin H. Hwang · University Of Minnesota · R37 · FY2024 · CA
Basic Cancer Research in Cancer Health Disparities
$370,462Radoslav Goldman · Georgetown University · U01 · FY2012 · CA
3-way approach for ED prevention
$370,459Carol Ann Podlasek · University Of Illinois At Chicago · R01 · FY2018 · DK
Role of alpha6 beta1 Integrin in Prostate Cancer
$370,449Cynthia K Miranti · Van Andel Research Institute · R01 · FY2014 · CA
The B7x pathways in the tumor microenvironment
$370,440Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Selenium molecular signaling in human prostate cancer
$370,417Roswell Park Cancer Institute Corp · R01 · FY2004 · CA
Hemostasis System in Tumor Growth and Metastasis
$370,415Victoria Ploplis · University Of Notre Dame · P01 · FY2008 · HL
Targeting the colchicine binding site in tubulin for cancer therapy
$370,326Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA
Sonic hedgehog:Insulin-Like Growth Factor Interactions in Proliferating Neural Pr
$370,321Anna Marie Kenney · Sloan-Kettering Inst Can Research · R01 · FY2010 · NS